Profiel
Charlie Qi is currently the Senior Vice President-Global Clinical Development at Transcenta Holding Ltd.
and the Head-Oncology Product Development at Roche Global Product Development Center.
Previously, he worked as the Head-Medical Sciences at Hutchison MediPharma Ltd.
from 2012 to 2017.
Actieve functies van Charlie Qi
| Bedrijven | Functie | Begin |
|---|---|---|
| TRANSCENTA HOLDING LIMITED | Chief Tech/Sci/R&D Officer | 01-08-2020 |
| Roche Global Product Development Center | Corporate Officer/Principal | 01-08-2017 |
Eerdere bekende functies van Charlie Qi
| Bedrijven | Functie | Einde |
|---|---|---|
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 01-08-2017 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TRANSCENTA HOLDING LIMITED | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
| Roche Global Product Development Center |
